series-a
Stage
1
Investors
About
Neurotrack develops FDA-registered digital cognitive assessment tools designed to detect mild cognitive impairment, dementia, and Alzheimer's disease earlier and with greater accuracy, integrating clinical workflows to support diagnosis and personalized care planning.
Explore Neurotrack's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.